MPN-SAF TSS
Showing 1 - 25 of 213
Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)
Not yet recruiting
- Myelofibrosis
- TQ05105 Tablets
- TQB3617 Capsules
-
Guangzhou, Guangdong, China
- +19 more
Nov 7, 2023
Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)
Not yet recruiting
- Bone Marrow Fibrosis
- Myeloproliferative Neoplasm
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023
Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)
Recruiting
- Myeloproliferative Neoplasm
- +2 more
- Fedratinib Pill
-
Tampa, FloridaMoffitt Cancer Center
Jun 15, 2022
Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)
Active, not recruiting
- Myeloproliferative Neoplasm
- +4 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Jan 6, 2023
Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- Leukemia
-
Tampa, Florida
- +4 more
Nov 11, 2022
Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)
Not yet recruiting
- Myeloproliferative Disorders
- Leukemia
- Cardiac Lifestyle Program
-
Boston, Massachusetts
- +2 more
May 1, 2023
A Prospective, Non-interventional Study of JAKAVI® Treatment in
Active, not recruiting
- Polycythemia Vera
- Jakavi
-
Reutlingen, Baden Wuerttemberg, Germany
- +98 more
May 16, 2023
Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)
Recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022
Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)
Enrolling by invitation
- Myelodysplastic/Myeloproliferative Neoplasms
- Adult
- venetoclax combined with azacitidine
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Mar 7, 2022
Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)
Recruiting
- Primary Myelofibrosis
- +9 more
- Observational
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 11, 2022
Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])
Recruiting
- Pre-fibrotic Myelofibrosis
- Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
-
Taipei, Taiwan, 100, TaiwanNational Taiwan University Hospital
Feb 7, 2023
Moderate and High Risk Myelofibrosis Trial in China (TQ05105 tablets, Hydroxycarbamide tablets)
Recruiting
- Moderate and High Risk Myelofibrosis
- TQ05105 tablets
- Hydroxycarbamide tablets
-
Beijing, Beijing, China
- +3 more
Nov 23, 2021
Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)
Recruiting
- Essential Thrombocythemia
- Ropeginterferon alfa-2b
- Anagrelide
-
Phoenix, Arizona
- +60 more
Dec 30, 2021
Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online
Recruiting
- Myeloproliferative Neoplasm
- +2 more
- Online Mindfulness Meditation
- Internet-Based Webinars
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 9, 2022
Phlebotomy Dependent Polycythemia Vera Trial in Canada, United Kingdom, United States (IONIS-TMPRSS6-LRx)
Recruiting
- Phlebotomy Dependent Polycythemia Vera
-
Orange, California
- +4 more
Aug 1, 2022
Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)
Recruiting
- Myeloproliferative Neoplasms
-
Herston, Queensland, Australia
- +22 more
Jun 30, 2023
Bone Marrow Fibrosis Trial in Germany (Allogeneic stem cell transplantation, Ruxolitinib continuous therapy)
Active, not recruiting
- Bone Marrow Fibrosis
- Allogeneic stem cell transplantation
- Ruxolitinib continuous therapy
-
Aachen, Germany
- +13 more
Aug 20, 2021
Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)
Recruiting
- Myelofibrosis
- Jaktinib hydrochloride tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 29, 2021
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston
Completed
- Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
Myeloproliferative Tumor Trial in New York (Vactosertib)
Recruiting
- Myeloproliferative Neoplasm
-
New York, New YorkWeill Medical College of Cornell University
Dec 20, 2021
Essential Thrombocythemia, Polycythemia Vera Trial in Boston (Ruxolitinib)
Not yet recruiting
- Essential Thrombocythemia
- Polycythemia Vera
-
Boston, Massachusetts
- +2 more
Nov 24, 2020